undamentalytics Newsletter
Sign in

Surgery Partners, Inc. cash flow statement

In fiscal 2025, Surgery Partners, Inc.'s operations generated $274m of cash; it spent $78.7m on capital projects, leaving free cash flow of $196m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2013Dec 20132014Dec 20142015Dec 20152016Dec 20162018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations49228412514513024787159294300274258
Depreciation and amortisation1215354067779599115118153176177
Stock-based pay018291013171818331510
Capital spending483339407443588189907970
Free cash flow45145186105562043078205210196188
Free cash flow after stock pay4413448496461911260187176181178
Share buybacks0300200——————
Shares issued—————0058288300——

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ACHC vs SGRYBKD vs SGRYCON vs SGRYPACS vs SGRY

More: Health Care Facilities stocks compared, Health Care sector, rankings of US companies

Figures from Surgery Partners, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Surgery Partners, Inc.